(Q38262087)

1 September 2017

1 reference

title

Chronic bladder ischemia and oxidative stress: new pharmacotherapeutic targets for lower urinary tract symptoms (English)

1 reference

1 September 2017

Masanori Nomiya

1

1 reference

PubMed ID

25339506

1 September 2017

Karl-Erik Andersson

series ordinal

2

1 reference

PubMed ID

25339506

1 September 2017

Osamu Yamaguchi

series ordinal

3

1 reference

1 September 2017

22 October 2014

1 reference

International Journal of Urology

1 September 2017

1 reference

1 September 2017

22

1 reference

1 September 2017

1

1 reference

1 September 2017

40-46

1 reference

Lower urinary tract symptoms revisited: a broader clinical perspective

1 September 2017

1 reference

Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study.

21 January 2018

1 reference

Place of overactive bladder in male lower urinary tract symptoms

21 January 2018

1 reference

Functional consequences of chronic bladder ischemia

21 January 2018

1 reference

Tadalafil for the treatment of lower urinary tract symptoms secondary to benign prostatic hyperplasia: pathophysiology and mechanism(s) of action

21 January 2018

1 reference

Association of lower urinary tract symptoms and chronic ischaemia of the lower urinary tract in elderly women and men: assessment using colour Doppler ultrasonography

21 January 2018

1 reference

The association between vascular risk factors and lower urinary tract symptoms in both sexes

21 January 2018

1 reference

The effect of bladder outflow obstruction on detrusor blood flow changes during the voiding cycle in conscious pigs

21 January 2018

1 reference

Oxidative modification of mitochondrial integrity and nerve fiber density in the ischemic overactive bladder.

21 January 2018

1 reference

Effects of ischemia on tachykinin-containing nerves and neurokinin receptors in the rabbit bladder.

21 January 2018

1 reference

Effect of melatonin on chronic bladder-ischaemia-associated changes in rat bladder function.

21 January 2018

1 reference

Increased bladder activity is associated with elevated oxidative stress markers and proinflammatory cytokines in a rat model of atherosclerosis-induced chronic bladder ischemia.

21 January 2018

1 reference

The effect of atherosclerosis-induced chronic bladder ischemia on bladder function in the rat.

21 January 2018

1 reference

Endothelial dysfunction and aging: an update

21 January 2018

1 reference

Free radical theory of aging

21 January 2018

1 reference

Association between Lower Urinary Tract Symptoms and Vascular Risk Factors in Aging Men: The Hallym Aging Study

21 January 2018

1 reference

Association between erectile dysfunction and coronary artery disease: Matching the right target with the right test in the right patient

21 January 2018

1 reference

The relationship between erectile dysfunction and lower urinary tract symptoms and the role of phosphodiesterase type 5 inhibitors

21 January 2018

1 reference

Association between lower urinary tract symptoms and erectile dysfunction.

21 January 2018

1 reference

Risk factors and comorbid conditions associated with lower urinary tract symptoms: EpiLUTS.

21 January 2018

1 reference

Lower urinary tract symptoms and sexual dysfunction: epidemiology and pathophysiology

21 January 2018

1 reference

Alteration of urothelial-mediated tone in the ischemic bladder: role of eicosanoids

21 January 2018

1 reference

Increased leukotriene and prostaglandin release, and overactivity in the chronically ischemic bladder

21 January 2018

1 reference

Molecular reactions and ultrastructural damage in the chronically ischemic bladder.

21 January 2018

1 reference

The effects of chronic hyperlipidemia on bladder function in myocardial infarction-prone Watanabe heritable hyperlipidemic (WHHLMI) rabbits

21 January 2018

1 reference

Effects of silodosin, a selective α1A-adrenoceptor antagonist, on bladder blood flow and bladder function in a rat model of atherosclerosis induced chronic bladder ischemia without bladder outlet obstruction

21 January 2018

1 reference

Suppression of bladder overactivity and oxidative stress by the phytotherapeutic agent, Eviprostat, in a rat model of atherosclerosis-induced chronic bladder ischemia.

21 January 2018

1 reference

Prophylactic effect of tadalafil on bladder function in a rat model of chronic bladder ischemia

21 January 2018

1 reference

Impaired detrusor contractility in a rat model of chronic bladder ischemia

21 January 2018

1 reference

Urinary bladder mucosal responses to ischemia

21 January 2018

1 reference

Progressive vascular damage may lead to bladder underactivity in rats

21 January 2018

1 reference

Initial validation of a novel rat model of vasculogenic erectile dysfunction with generalized atherosclerosis

21 January 2018

1 reference

An animal model to study lower urinary tract symptoms and erectile dysfunction: the hyperlipidaemic rat.

21 January 2018

1 reference

Do atherosclerosis and chronic bladder ischemia really play a role in detrusor dysfunction of old age?

21 January 2018

1 reference

Reactive oxygen species mediate detrusor overactivity via sensitization of afferent pathway in the bladder of anaesthetized rats

21 January 2018

1 reference

Pharmacological treatment of chronic pelvic ischemia

21 January 2018

1 reference

Latest treatment for lower urinary tract dysfunction: therapeutic agents and mechanism of action

21 January 2018

1 reference

The forefront for novel therapeutic agents based on the pathophysiology of lower urinary tract dysfunction: alpha-blockers in the treatment of male voiding dysfunction - how do they work and why do they differ in tolerability?

21 January 2018

1 reference

Urodynamic effects of alpha-adrenoceptor blockers: a review of clinical trials

21 January 2018

1 reference

alpha-Blockers improve chronic ischaemia of the lower urinary tract in patients with lower urinary tract symptoms

21 January 2018

1 reference

Effect of tamsulosin on bladder microcirculation in a rat ischemia-reperfusion model, evaluated by pencil lens charge-coupled device microscopy system

21 January 2018

1 reference

Effect of tamsulosin on bladder blood flow and bladder function in a rat model of bladder over distention/emptying induced bladder overactivity.

21 January 2018

1 reference

Erectile dysfunction and lower urinary tract symptoms secondary to BPH.

21 January 2018

1 reference

Lower urinary tract symptoms and male sexual dysfunction: the multinational survey of the aging male (MSAM-7).

21 January 2018

1 reference

Sexual dysfunction and lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH).

21 January 2018

1 reference

Endogenous nitric oxide/cGMP signalling in the guinea pig bladder: evidence for distinct populations of sub-urothelial interstitial cells

21 January 2018

1 reference

Phosphodiesterase 1 inhibition in the treatment of lower urinary tract dysfunction: from bench to bedside

21 January 2018

1 reference

Antiinflammatory properties of HDL.

21 January 2018

1 reference

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

Effect of edaravone on ischemia/reperfusion injury in rat urinary bladder--changes in smooth muscle cell phenotype and contractile function

21 January 2018

1 reference

Coenzyme Q10 diminishes ischemia-reperfusion induced apoptosis and nerve injury in rabbit urinary bladder

21 January 2018

1 reference

Effect of the phytotherapeutic agent eviprostat on the bladder in a rat model of bladder overdistension/emptying

21 January 2018

1 reference

Suppression of bladder oxidative stress and inflammation by a phytotherapeutic agent in a rat model of partial bladder outlet obstruction.

21 January 2018

1 reference

Melatonin treatment protects against ischemia/reperfusion-induced functional and biochemical changes in rat urinary bladder

21 January 2018

1 reference

Acute urinary retention and subsequent catheterization cause lipid peroxidation and oxidative DNA damage in the bladder: preventive effect of edaravone, a free-radical scavenger

21 January 2018

1 reference

Selective β₃-adrenoceptor agonists for the treatment of overactive bladder

21 January 2018

1 reference

Results of a randomized phase III trial of mirabegron in patients with overactive bladder

21 January 2018

1 reference

A phase II dose-ranging study of mirabegron in patients with overactive bladder

21 January 2018

1 reference

Phase III, randomised, double-blind, placebo-controlled study of the β3-adrenoceptor agonist mirabegron, 50 mg once daily, in Japanese patients with overactive bladder.

21 January 2018

1 reference

Effects of mirabegron, a novel β3-adrenoceptor agonist, on primary bladder afferent activity and bladder microcontractions in rats compared with the effects of oxybutynin.

21 January 2018

1 reference

Modulation of non-voiding activity by the muscarinergic antagonist tolterodine and the β(3)-adrenoceptor agonist mirabegron in conscious rats with partial outflow obstruction.

21 January 2018

1 reference

Restoration of the cAMP second messenger pathway enhances cardiac preservation for transplantation in a heterotopic rat model

21 January 2018

1 reference

The enhancement of endogenous cAMP with pituitary adenylate cyclase-activating polypeptide protects rat kidney against ischemia through the modulation of inflammatory response.

21 January 2018

1 reference

Protective effect of a β3-adrenoceptor agonist on bladder function in a rat model of chronic bladder ischemia.

21 January 2018

1 reference

Signal transduction underlying the control of urinary bladder smooth muscle tone by muscarinic receptors and beta-adrenoceptors

21 January 2018

1 reference

Involvement of cyclic AMP-dependent and -independent mechanisms in the relaxation of rat detrusor muscle via beta-adrenoceptors

21 January 2018

1 reference

Cytoprotective action of the potassium channel opener NS1619 under conditions of disrupted calcium homeostasis.

21 January 2018

1 reference

ATP-regulated K+ channels protect the myocardium against ischemia/reperfusion damage

21 January 2018

1 reference

Cytoprotective role of Ca2+- activated K+ channels in the cardiac inner mitochondrial membrane

21 January 2018

1 reference

Sexual Dysfunction and Cardiac Risk (the Second Princeton Consensus Conference)

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/IJU.12652

1 reference

1 September 2017

1 reference

PubMed ID

25339506